March 5, 2025
In the News
February 6, 2025
In Vivo: Artiva Leverages Unmodified NK Cells To Challenge CAR-T Paradigm
January 28, 2025
Drug Discovery World: Expanding Access to Cell Therapies for Autoimmune Conditions
January 27, 2025
PharmaVoice: Natural Killer Cells, a Rising Alternative to CAR-T Cell Therapy
January 16, 2025
Cell & Gene The Podcast: The Future of NK Cell Therapy for Autoimmune Disease
November 18, 2024
PharmaShots: Enhancing Care with NK Cell Therapy
November 4, 2024
BioProcess Insider: Artiva Discusses Scalable NK Cells to Treat Autoimmune Diseases
August 16, 2024
BiotechTV: Checking in with Artiva CEO Fred Aslan after the Company’s $167 Million IPO
May 30, 2024
Pharmaphorum Podcast: Move over CAR-T – the Potential of NK Cells in Cell Therapy
April 24, 2024